首站-论文投稿智能助手
典型文献
Associations between cancer family history and esophageal cancer and precancerous lesions in high-risk areas of China
文献摘要:
Background::Family clustering of esophageal cancer (EC) has been found in high-risk areas of China. However, the relationships between cancer family history and esophageal cancer and precancerous lesions (ECPL) have not been comprehensively reported in recent years. This study aimed to provide evidence for identification of high-risk populations.Methods::This study was conducted in five high-risk areas in China from 2017 to 2019, based on the National Cohort of Esophageal Cancer. The permanent residents aged 40 to 69 years were examined by endoscopy, and pathological examination was performed for suspicious lesions. Information on demographic characteristics, environmental factors, and cancer family history was collected. Unconditional logistic regression was applied to evaluate odds ratios between family history related factors and ECPL.Results::Among 33,008 participants, 6143 (18.61%) reported positive family history of EC. The proportion of positive family history varied significantly among high-risk areas. After adjusting for risk factors, participants with a family history of positive cancer, gastric and esophageal cancer or EC had 1.49-fold (95% confidence interval [CI]: 1.36-1.62), 1.52-fold (95% CI: 1.38-1.67), or 1.66-fold (95% CI: 1.50-1.84) higher risks of ECPL, respectively. Participants with single or multiple first-degree relatives (FDR) of positive EC history had 1.65-fold (95% CI: 1.47-1.84) or 1.93-fold (95% CI: 1.46-2.54) higher risks of ECPL. Participants with FDRs who developed EC before 35, 45, and 50 years of age had 4.05-fold (95% CI: 1.30-12.65), 2.11-fold (95% CI: 1.37-3.25), and 1.91-fold (95% CI: 1.44-2.54) higher risks of ECPL, respectively.Conclusions::Participants with positive family history of EC had significantly higher risk of ECPL. This risk increased with the number of EC positive FDRs and EC family history of early onset. Distinctive genetic risk factors of the population in high-risk areas of China require further investigation.Trial registration::ChiCTR-EOC-17010553.
文献关键词:
Esophageal cancer;Family history;High-risk area;Cross-sectional study
作者姓名:
Zhou Jiachen;Sun Kexin;Wang Shaoming;Chen Ru;Li Minjuan;Gu Jianhua;Fan Zhiyuan;Zhuang Guihua;Wei Wenqiang
作者机构:
Department of Epidemiology and Biostatistics, School of Public Health, Xl’an Jiaotong University Health Science Center, Xi’an, Shaanxi 710061, China;National Central Cancer Registry, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
引用格式:
[1]Zhou Jiachen;Sun Kexin;Wang Shaoming;Chen Ru;Li Minjuan;Gu Jianhua;Fan Zhiyuan;Zhuang Guihua;Wei Wenqiang-.Associations between cancer family history and esophageal cancer and precancerous lesions in high-risk areas of China)[J].中华医学杂志(英文版),2022(07):813-819
A类:
ECPL,Unconditional,FDRs
B类:
Associations,between,family,history,esophageal,precancerous,lesions,areas,China,Background,Family,clustering,has,been,found,However,relationships,have,not,comprehensively,reported,recent,years,This,study,aimed,provide,evidence,identification,populations,Methods,was,conducted,five,from,National,Cohort,Esophageal,Cancer,permanent,residents,aged,were,examined,by,endoscopy,pathological,examination,performed,suspicious,Information,demographic,characteristics,environmental,factors,collected,logistic,regression,applied,evaluate,odds,ratios,related,Results,Among,participants,positive,proportion,varied,significantly,among,After,adjusting,gastric,had,fold,confidence,interval,higher,risks,respectively,Participants,single,multiple,first,degree,relatives,who,developed,before,Conclusions,increased,number,early,onset,Distinctive,genetic,require,further,investigation,Trial,registration,ChiCTR,EOC,High,Cross,sectional
AB值:
0.422692
相似文献
Comprehensive characterization of CRC with germline mutations reveals a distinct somatic mutational landscape and elevated cancer risk in the Chinese population
Jianfei Yao;Yunhuan Zhen;Jing Fan;Yuan Gong;Yumeng Ye;Shaohua Guo;Hongyi Liu;Xiaoyun Li;Guosheng Li;Pan Yang;Xiaohui Wang;Danni Liu;Tanxiao Huang;Huiya Cao;Peisu Suo;Yuemin Li;Jingbo Yu;Lele Song-Department of Radiotherapy,the Eighth Medical Center of the Chinese PLA General Hospital,Beijing 100091,China;HaploX Biotechnology,Shenzhen 518057,China;Department of Colorectal Surgery,Affiliated Hospital of Guizhou Medical University,Guiyang 550004,China;International Business School,Beijing Foreign Studies University,Beijing 100089,China;Department of Gastroenterology,the Second Medical Center of the Chinese PLA General Hospital,Beijing 100853,China;Department of Experimental Pathology,Beijing Institute of Radiation Medicine,Beijing 100850,China;Department of General Surgery,the First Medical Center of the Chinese PLA General Hospital,Beijing 100853,China;Department of Hepatobiliary Surgery,Dalian Municipal Central Hospital,Dalian Medical University,Dalian 116033,China;Comprehensive Liver Cancer Department,the Fifth Medical Center of the Chinese PLA General Hospital,Beijing 100039,China
Development and evaluation of the screening performance of a low-cost high-risk screening strategy for breast cancer
Yubei Huang;Huan Wang;Zhangyan Lyu;Hongji Dai;Peifang Liu;Ying Zhu;Fengju Song;Kexin Chen-Department of Cancer Epidemiology and Biostatistics,Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy of Tianjin,Tianjin's Clinical Research Center for Cancer,Key Laboratory of Cancer Molecular Epidemiology of Tianjin,Key Laboratory of Breast Cancer Prevention and Therapy,Ministry of Education,Tianjin 300060,China;Department of Breast Imaging,Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy of Tianjin,Tianjin's Clinical Research Center for Cancer,Key Laboratory of Cancer Molecular Epidemiology of Tianjin,Key Laboratory of Breast Cancer Prevention and Therapy,Ministry of Education,Tianjin 300060,China
Treatment outcomes of HIV patients with hepatitis B and C virus co-infections in Southwest China: an observational cohort study
Jia Jingya;Zhu Qiuying;Deng Luojia;Lan Guanghua;Johnson Andrew;Chen Huanhuan;Shen Zhiyong;Li Jianjun;Xing Hui;Ruan Yuhua;Li Jing;Lu Hui;Vermund Sten H.;Zhu Jinhui;Qian Han-Zhu-SJTU-Yale Joint Center for Biostatistics and Data Science, Shanghai Jiao Tong University, Shanghai, China;Department of Bioinformatics and Biostatistics, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, China;Guangxi Key Laboratory of Major Infectious Disease Prevention Control and Biosafety Emergency Response, Guangxi Center for Disease Control and Prevention, Nanning, China;Groton School, Groton, MA, USA;State Key Laboratory of Infectious Disease Prevention and Control (SKLID), Chinese Center for Disease Control and Prevention (China CDC), Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Beijing, China;School of Public Health, Yale University, New Haven, CT, USA
Profile and determinants of delayed care-seeking and diagnosis among patients with imported malaria: a retrospective study in China, 2014–2021
Zhang Tao;Wang Duoquan;Qian Yingjun;Ruan Wei;Liu Ying;Xia Jing;Yan Hui;Sui Yuan;Lu Shenning;Xu Xian;Jiang Jingjing;Lyu Xiaofeng;Wang Shuqi;Li Shizhu;Li Weidong-Anhui Provincial Center for Disease Control and Prevention, Hefei 230601, China;National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention (Chinese Center for Tropical Diseases Research), NHC Key Laboratory of Parasite and Vector Biology, WHO Collaborating Center for Tropical Diseases, National Center for International Research on Tropical Diseases, Shanghai 200025, China;School of Global Health, Chinese Center for Tropical Diseases Research, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China;Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou 310051, China;Henan Provincial Center for Disease Control and Prevention, Zhengzhou 450016, China;Hubei Provincial Center for Disease Control and Prevention, Wuhan 430079, China;Guangxi Zhuang Autonomous Region Center for Disease Control and Prevention, Nanning 530028, China;Brown School, Washington University, St. Louis, MO, USA
Predictors of pathologic complete response in patients with residual flat mucosal lesions after neoadjuvant chemoradiotherapy for locally advanced rectal cancer
Changlong Li;Zhen Guan;Yi Zhao;Tingting Sun;Zhongwu Li;Weihu Wang;Zhexuan Li;Lin Wang;Aiwen Wu-Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Gastrointestinal Cancer Center,Peking University Cancer Hospital&Institute,Beijing 100142,China;Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Department of Radiology,Peking University Cancer Hospital&Institute,Beijing 100142,China;Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Department of Pathology,Peking University Cancer Hospital&Institute,Beijing 100142,China;Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Department of Radiation Oncology,Peking University Cancer Hospital&Institute,Beijing 100142,China;Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Department of Cancer Epidemiology,Peking University Cancer Hospital&Institute,Beijing 100142,China
Evaluation of triage strategies for high-risk human papillomavirus-positive women in cervical cancer screening:A multicenter randomized controlled trial in different resource settings in China
Le Dang;Linghua Kong;Yuqian Zhao;Yi Dai;Li Ma;Lihui Wei;Shulan Zhang;Jihong Liu;Mingrong Xi;Long Chen;Xianzhi Duan;Qing Xiao;Guzhalinuer Abulizi;Guonan Zhang;Ying Hong;Qi Zhou;Xing Xie;Li Li;Mayinuer Niyazi;Zhifen Zhang;Jiyu Tuo;Yiling Ding;Youlin Qiao;Jinghe Lang-Department of Gynecology and Obstetrics,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences/Peking Union Medical College,Beijing 100730,China;National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China;Center for Cancer Prevention Research,Sichuan Cancer Hospital and Institute,Sichuan Cancer Center,School of Medicine,University of Electronic Science and Technology of China,Chengdu 610041,China;Department of Epidemiology,Dalian Medical University,Dalian 116044,China;Department Obstetrics and Gynecology,Peking University People's Hospital,Beijing 100044,China;Department of Obstetrics and Gynecology,Shengjing Hospital Affiliated to China Medical University,Shenyang 110004,China;Department of Gynecology and Obstetrics,Sun Yat-sen University Cancer Center,Guangzhou 510060,China;Department of Gynecology and Obstetrics,West China Second University Hospital,Sichuan University,Chengdu 610041,China;Department of Gynecology and Obstetrics,Zhejiang Xiaoshan Hospital Affiliated to Hangzhou Normal University,Chinese Academy of Medical Sciences/Zhejiang Xiaoshan Hospital Affiliated to Hangzhou Normal University,Hangzhou 310000,China;Department of Obstetrics and Gynecology,Beijing Tongren Hospital,Capital Medical University,Beijing 100730,China;Department of Gynecology and Obstetrics,the Eight Affiliated Hospital Sun Yat-sen University,Shenzhen 518000,China;125th Department of Gynecology,the Affiliated Cancer Hospital of Xinjiang Medical University,Urumqi 830011,China;Department of Gynecologic Oncology,Sichuan Cancer Hospital&Institute,Sichuan Cancer Center,School of Medicine,University of Electronic Science and Technology of China,Chengdu 610041,China;Department of Gynecology and Obstetrics,Nanjing Drum Tower Hospital,Affiliated Hospital of Nanjing University Medical School,Nanjing 210008,China;Department of Gynecological Oncology,Chongqing University Cancer Hospital/Chongqing Cancer Hospital,Chongqing 400030,China;Department of Gynecologic Oncology,Women's Hospital,School of Medicine Zhejiang University,Hangzhou 310006,China;Department of Gynecology and Obstetrics,Tumor Hospital of Guangxi Zhuang Autonomous Region,Nanning 530021,China;Department of Gynecology,People's Hospital of Xinjiang Uygur Autonomous Region,Urumqi 830000,China;Department of Gynecology,Hangzhou Women's Hospital,Hangzhou 310016,China;Department of Gynecology and Obstetrics,Hubei Cancer Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430079,China;Department of Gynecology and Obstetrics,the Second Xiangya Hospital of Central South University,Changsha 410011,China;School of Population Medicine and Public Health,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100005,China
Adjuvant tamoxifen switched to exemestane treatment in postmenopausal women with estrogen receptor-positive early breast cancer: A pragmatic, multicenter, and prospective clinical trial in China
Binghe Xu;Huiping Li;Zefei Jiang;Lin Gu;Jinhai Tang;Hui Xie;Yueyin Pan;Yunjiang Liu;Shude Cui;Xiaojia Wang;Li Cai;Yiqiong Zhang;Huadong Zhao;Zhimin Shao-Department of Medical Oncology,National Cancer Center/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China;Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Department of Breast Oncology,Peking University Cancer Hospital&Institute,Beijing 100142,China;Department of Breast Cancer,the Fifth Medical Center of Chinese PLA General Hospital,Beijing 100071,China;Department of Breast Cancer,Tianjin Cancer Institute and Hospital,Tianjin 300060,China;Department of Breast Cancer,Jiangsu Provincial Hospital,Nanjing 210029,China;Department of Breast Cancer,the First Affiliated Hospital of China University of Science and Technology,Hefei 230001,China;Department of Breast Cancer,the Fourth Hospital of Hebei Medical University,Shijiazhuang 050011,China;Department of Breast Cancer,Henan Cancer Hospital,Zhengzhou 450008,China;Department of Breast Cancer,Zhejiang Cancer Hospital,Hangzhou 310012,China;Department of Breast Cancer,Harbin Medical University Cancer Hospital,Harbin 150081,China;Department of Clinical Development,Pfizer(China)R&D Co.Ltd,Shanghai 201203,China;Department of Statistics,Pfizer(China)R&D Co.Ltd,Shanghai 201203,China;Department of Breast Surgery,Shanghai Cancer Center/Cancer Institute,Shanghai Medical College,Fudan University,Shanghai 200032,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。